You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(02359.HK)11月7日完成2018年股權激勵計劃預留授予登記工作
格隆匯 11-08 17:42

格隆匯11月8日丨藥明康德(02359.HK)公告,公司第一屆董事會第二十次會議和第2018年第二次臨時股東大會分別審議通過了《關於審議 <無錫藥明康德新藥開發股份有限公司2018年限制性股票與股票期權激勵計劃(草案)> 及其摘要的議案》,同意公司實行2018年限制性股票與股票期權激勵計劃項目。根據《上市公司股權激勵管理辦法》、上海證券交易所及中國證券登記結算有限責任公司上海分公司(以下簡稱“中證登上海分公司”)有關業務規則的規定,公司於2019年11月8日收到中證登上海分公司出具的《證券變更登記證明》。根據《證券變更登記證明》,公司於2019年11月7日完成了2018年股權激勵計劃預留授予部分權益授予的登記工作。

股權激勵權益登記日:2019年11月7日。股權激勵權益登記數量:限制性股票47.8822萬股,股票期權28.7萬份。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account